Daniel Sharp
Director/Board Member bij ALCIDION GROUP LIMITED
Vermogen: 531 764 $ op 31-03-2024
Profiel
Daniel Sharp is currently a Non-Executive Director at Botanix Pharmaceuticals Ltd.
and an Independent Non-Executive Director at Alcidion Group Ltd.
He previously served as an Independent Non-Executive Director at ImpediMed Ltd.
in 2023, an Executive Director at Shaw & Partners Corporate Finance Pty Ltd., and an Executive Director at Canaccord Genuity (Australia) Ltd.
from 2012 to 2020.
He also served as an Independent Non-Executive Director at Race Oncology Ltd.
in 2022-2023.
Mr. Sharp received his undergraduate and graduate degrees from Monash University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMPEDIMED LIMITED
0.41% | 28-09-2023 | 8 234 192 ( 0.41% ) | 494 216 $ | 31-03-2024 |
ALCIDION GROUP LIMITED
0.08% | 30-06-2023 | 1 128 572 ( 0.08% ) | 37 548 $ | 31-03-2024 |
Actieve functies van Daniel Sharp
| Bedrijven | Functie | Begin |
|---|---|---|
| ALCIDION GROUP LIMITED | Director/Board Member | 01-09-2021 |
| BOTANIX PHARMACEUTICALS LIMITED | Director/Board Member | 22-03-2022 |
Eerdere bekende functies van Daniel Sharp
| Bedrijven | Functie | Einde |
|---|---|---|
| IMPEDIMED LIMITED | Director/Board Member | 28-09-2023 |
| RACE ONCOLOGY LIMITED | Director/Board Member | 29-06-2023 |
Canaccord Genuity (Australia) Ltd.
 Canaccord Genuity (Australia) Ltd. Investment Banks/BrokersFinance Canaccord Genuity (Australia) Ltd. (Canaccord Genuity Australia) is the Australian full service stockbroking and wealth management subsidiary of Canaccord Genuity Group Inc. (TSE: CF) in Canada. Headquartered in Melbourne, Canaccord Genuity Australia was founded by Anthony Murphy and provides wealth management services including portfolio management, portfolio administration and broking services to individual, institutional and corporate clients. | Director/Board Member | 01-01-2020 |
Shaw & Partners Corporate Finance Pty Ltd.
 Shaw & Partners Corporate Finance Pty Ltd. Investment Banks/BrokersFinance Part of EFG International AG, Shaw & Partners Corporate Finance Pty Ltd. is a brokerage firm founded in 1987. The private company is based in Sydney, Australia and provides brokerage services. | Corporate Officer/Principal | - |
Opleiding van Daniel Sharp
| Monash University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
| IMPEDIMED LIMITED | Health Technology |
| ALCIDION GROUP LIMITED | Technology Services |
| RACE ONCOLOGY LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Shaw & Partners Corporate Finance Pty Ltd.
Shaw & Partners Corporate Finance Pty Ltd. Investment Banks/BrokersFinance Part of EFG International AG, Shaw & Partners Corporate Finance Pty Ltd. is a brokerage firm founded in 1987. The private company is based in Sydney, Australia and provides brokerage services. | Finance |
Canaccord Genuity (Australia) Ltd.
Canaccord Genuity (Australia) Ltd. Investment Banks/BrokersFinance Canaccord Genuity (Australia) Ltd. (Canaccord Genuity Australia) is the Australian full service stockbroking and wealth management subsidiary of Canaccord Genuity Group Inc. (TSE: CF) in Canada. Headquartered in Melbourne, Canaccord Genuity Australia was founded by Anthony Murphy and provides wealth management services including portfolio management, portfolio administration and broking services to individual, institutional and corporate clients. | Finance |
